VEGFA and hepatocellular carcinoma: In addition, DEB-TACE is sometimes performed for patients with large HCC; however, there is often high risk of residual cancer at the tumor margins, or that the VEGF, FGF, angiopoietin-2 will be released, inducing rapid recurrence and metastasis.